Citromustine -100mg Carmustine for Injection USP is a medication used mainly for chemotherapy and sometimes for immunosuppression before organ transplantation. It is a nitrogen mustard β-chloro-nitrosourea compound used as an alkylating agent. As a dialkylating agent,Carmustine is able to form interstrand crosslinks in DNA, which prevents DNA replication and DNA transcription
CITROBICIN Daunorubicin for Injection USP 20mg is a chemotherapy medication used to treat cancer. Specifically it is used for acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma It is used by injection into a vein.
CITROBICIN Daunorubicin for Injection USP 20mg is a chemotherapy medication used to treat cancer. Specifically it is used for acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma It is used by injection into a vein.
Citrodactino Dactinomycin for injection USP is a chemotherapy medication used to treat a number of types of cancer. This includes Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, trophoblastic neoplasm, testicular cancer, and certain types of ovarian cancer. It is given by injection into a vein
Citroleomycin-15units /Vial Bleomycin for injection USPis a medication used to treat cancer. This includes Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, ovarian cancer, and cervical cancer among others. Typically used with other cancer medications, it can be given intravenously, by injection into a muscle or under the skin. It may also be administered inside the chest to help prevent the recurrence of a fluid around the lung due to cancer.
Citromercapt Mercaptopurine Tablets BP, used for cancer and autoimmune diseases. Specifically it is used to treat acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), Crohn's disease, and ulcerative colitis.
Citronoin Tretinoin Capsule 10mg is used to treat a certain type of cancer of the white blood cells (APL-acute promyelocytic leukemia). APL is a disease of too many white blood cells that do not mature or function properly.
Citropeginase Pegaspargase Injection -5ml is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation.It is used in the treatment of acute lymphoblastic leukemia
Citroposide,Etoposide injection USP is a chemotherapy medication used for the treatments of a number of types of cancer. This includes testicular cancer, luncancer, lymphoma, leukemia, neuroblastoma, and ovarian cancer.
Citrotrexate Methotrexate Injection BP -1g is a chemotherapy agent and immune system suppressant. It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions. Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, and osteosarcoma. Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn's disease.
Citromine Tablets 2.5mg Methotrexate Tablets BP is a chemotherapy agent and immune system suppressant. It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions. Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, and osteosarcoma. Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn's disease.
CITROPHAMIDE -5000 Cyclophosmide for injection USP 500mg is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. As an immune suppressor it is used in nephrotic syndrome and following organ transplant
1 | BLEOMYCIN FOR INJECTION USP 15 UNITS BLEOCEL 15 | Each sterile lyophilized single dose vial contains Bleomycin sulfate USP equivalent to Bleomycin activity | 15 Units |
2 | BUSULFAN INJECTION 60mg/10 ml BUSULON 60 | Each ml contains Busulfan USP | 6 mg |
3 | CARBOPLATIN INJECTION BP 150 mg/15 ml | Each ml contains Carboplatin BP | 10 mg |
4 | CARBOPLATIN INJECTION BP 450 mg/45 ml | Each ml contains Carboplatin BP | 10 mg |
5 | CISPLATIN INJECTION BP 10 mg/10 ml | Each ml contains Cisplatin BP Sodium chloride BP | 1 mg, 9mg |
6 | CISPLATIN INJECTION BP 50 mg /50 ml | Cisplatin BP Sodium chloride BP | 1 mg, 9mg |
7 | CLADRIBINE INJECTION 10 mg/10 Ml | Each ml contains Cladribine USP Sodium Chloride USP | 1 mg, q.s. |
8 | CYCLOPHOSPHAMIDE INJECTION IP 500 mg | Each sterile vial contains Cyclophosphamide monohydrate equivalent to Cyclophosphamide | 500 mg |
9 | CYCLOPHOSPHAMIDE INJECTION IP 1000 mg | Each sterile vial contains Cyclophosphamide monohydrate equivalent to Cyclophosphamide | 1000 mg |
10 | CYTARABINE INJECTION 100 mg/ 1 ml | Each ml contains Cytarabine USP | 100 mg |
11 | CYTARABINE INJECTION 500 mg/ 5 ml | Each ml contains Cytarabine USP | 100 mg |
12 | CYTARABINE INJECTION 1000 mg/ 10 ml | Each ml contains Cytarabine USP | 100 mg |
13 | CYTARABINE INJECTION 2000 mg/ 20 ml | Each ml contains Cytarabine USP | 100 mg |
14 | DACARBAZINE FOR INJECTION USP 100 mg | Each sterile lyophilized vial contains Dacarbazine USP | 100 mg |
15 | DACARBAZINE FOR INJECTION USP 200 mg | Each sterile lyophilized vial contains Dacarbazine USP | 200 mg |
16 | DACARBAZINE FOR INJECTION USP 500 mg | Each sterile lyophilized vial contains Dacarbazine USP | 500 mg |
17 | DACTINOMYCIN FOR INJECTION USP 0.5 MG | Each sterile lyophilized vial contains Dactinomycin USP Mannitol USP | 0.5 mg, 20mg |
18 | DAUNORUBICIN HYDROCHLORIDE FOR INJECTION USP 20 mg | Each sterile lyophilized vial contains Daunorubicin HYDROCHLORIDE USP equivalent TO Daunorubicin | 20 mg |
19 | DOCETAXEL INJECTION CONCENTRATE 20 mg/0.5 ml WITH SOLVENT FOR DOCETAXEL INJECTION CONCENTRTE 20 mg |
Each combipack contains
ONE VIAL OF DOCETAXEL INJECTION CONCENTRATE 20 mg/0.5 ml:
Each sterile vial contains
Anhydrous Docetaxel Polysorbate 80 USNF ONE VIAL OF SOLVENT FOR DOCETAXEL INJECTION CONCENTRATE 20 mg: Each sterile vial contains Alcohol (95% v/v) USP 13% w/v (Absolute alcohol content 15.25 % v/v) Water for injection USP |
20 mg q.s to 0.5 ml
13% w/v q.s to 1.5 ml |
20 | DOCETAXEL INJECTION CONCENTRATE 80 mg/2.0 ml WITH SOLVENT FOR DOCETAXEL INJECTION CONCENTRTE 80 mg |
Each combipack contains
ONE VIAL OF DOCETAXEL INJECTION CONCENTRATE 80 mg/2.0 ml:
Each sterile vial contains
Anhydrous Docetaxel
Polysorbate 80 USNF ONE VIAL OF SOLVENT FOR DOCETAXEL INJECTION CONCENTRATE 80 mg: Each sterile vial contains Alcohol (95% v/v) USP (Absolute alcohol content 15.25% v/v) Water for injection USP |
80 mg q.s to 2.0 ml
13% w/v q.s to 6.0 ml |
21 | DOCETAXEL INJECTION CONCENTRATE 120 mg/3.0 ml WITH SOLVENT FOR DOCETAXEL INJECTION CONCENTRTE 120 mg |
Each combipack contains
ONE VIAL OF DOCETAXEL INJECTION CONCENTRATE 120 mg/3.0 ml:
Each sterile vial contains
Anhydrous Docetaxel
Polysorbate 80 USNF ONE VIAL OF SOLVENT FOR DOCETAXEL INJECTION CONCENTRATE 120 mg: Each sterile vial contains Alcohol (95% v/v) USP(Absolute alcohol content 15.25% v/v) Water for injection USP |
80 mg q.s to 2.0 ml
13% w/v q.s to 9.0 ml |
22 | DOXORUBICIN HYDROCHLORIDE INJECTION USP 10 mg/5 ml | Each ml contains Doxorubicin hydrochloride USP Sodium chloride USP | 2 mg, 9 mg |
23 | DOXORUBICIN HYDROCHLORIDE INJECTION USP 50 mg/25 ml | Each ml contains Doxorubicin hydrochloride USP Sodium chloride USP | 2 mg, 9 mg |
24 | DOXORUBICIN HYDROCHLORIDE INJECTION USP 10 mg | Each sterile lyophilized vial contains Doxorubicin hydrochloride USP Lactose USP | 10 mg q.s. |
25 | DOXORUBICIN HYDROCHLORIDE INJECTION USP 50 mg | Each sterile lyophilized vial contains Doxorubicin hydrochloride USP Lactose USP | 50 mg q.s. |
26 | DOXORUBICIN HYDROCHLORIDE LYPOSOMAL INJECTION 20 mg/10 ml | Each ml contains Doxorubicin hydrochloride | 2 mg |
27 | DOXORUBICIN HYDROCHLORIDE LYPOSOMAL INJECTION 50 mg/25 ml | Each ml contains Doxorubicin hydrochloride | 2 mg |
28 | EPIRUBICIN HYDROCHLORIDE FOR INJECTION 10 mg | Each sterile lyophilized vial contains Epirubicin hydrochloride Ph.Eur Lactose USNF | 10 mg, 50 mg |
29 | Each sterile lyophilized vial contains | Epirubicin hydrochloride Ph.Eur Lactose USNF | 50 mg, 250 mg |
30 | ETOPOSIDE INJECTION USP 100 mg/5ml | Each ml contains Etoposide USP Benzyl alcohol USP Dehydrated alcohol USP | 20 mg, 30 mg, 30.5% w/v |
31 | FLUDARABINE PHOSPHATE FOR INJECTION USP 50 mg | Each sterile lyophilized single dose vial contains Fludarabine phosphate USP Mannitol USP | 50 mg |
32 | FLUOROURACIL INJECTION USP 250 mg / 5 ml | Each ml contains Fluorouracil USP | 50 mg |
33 | FLUOROURACIL INJECTION USP 500 mg / 10 ml | Each ml contains Fluorouracil USP | 50 mg |
33 | FLUOROURACIL INJECTION USP 500 mg / 10 ml | Each ml contains Fluorouracil USP | 50 mg |
34 | FOTEMUSTINE FOR INJECTION 200 mg | Each sterile lyophilized vial contains Fotemustine | 200 mg |
35 | GEMCITABINE FOR INJECTION USP 200 mg | Each sterile lyophilized vial contains Gemcitabine hydrochloride USP equivalent to Gemcitabine | 200 mg |
36 | GEMCITABINE FOR INJECTION USP 1000 mg | Each sterile lyophilized vial contains Gemcitabine hydrochloride USP equivalent to Gemcitabine | 1000 mg |
37 | IDARUBICIN HYDROCHLORIDE FOR INJECTION USP 5 mg | Each sterile lyophilized vial contains Idarubicin hydrochloride USP Lactose USNF | 5 mg q.s. |
38 | IDARUBICIN HYDROCHLORIDE FOR INJECTION USP 10 mg | Each sterile lyophilized vial contains Idarubicin hydrochloride USP Lactose USNF | 10 mg q.s. |
39 | IFOSFAMIDE FOR INJECTION USP 500 mg | Each sterile vial contains Ifosfamide USP | 500 mg |
40 | IFOSFAMIDE FOR INJECTION USP 1000 mg | Each sterile vial contains Ifostamide USP | 1000 mg |
41 | IFOSFAMIDE FOR INJECTION USP 2000 mg | Each sterile vial contains Ifostamide USP | 1000 mg |
42 | IFOSFAMIDE FOR INJECTION USP 3000 mg | Each sterile vial contains Ifostamide USP | 3000 mg |
43 | IRINOTECAN HYDROCHLORIDE TRIHYDRATE INJECTION 40 mg/2 ml | Each ml contains Irinotecan Hydrochloride Trihydrate Sorbitol USNF Lactic acid USP | 20 mg, 45 mg, 0.9 mg |
44 | IRINOTECAN HYDROCHLORIDE TRIHYDRATE INJECTION 100 mg/5 ml | Each ml contains Irinotecan Hydrochloride Trihydrate Sorbitol USNF Lactic acid USP | 20 mg, 45 mg, 0.9 mg |
45 | L-ASPARAGINASE FOR INJECTION 10000 IU | Each sterile lyophilized vial contains L-Asparaginase | 5000 IU |
46 | L-ASPARAGINASE FOR INJECTION 10000 IU | Each sterile lyophilized vial contains L-Asparaginase | 10000 IU |
47 | METHOTREXATE INJECTION USP 15 mg/ 3 ml | Each ml contains Methotrexate USP Sodium chloride USP Water for injection USP | 5 mg 0.490% w/v q.s |
48 | METHOTREXATE INJECTION USP 50 mg/2 ml | Each ml contains Methotrexate USP Sodium chloride USP Water for injection USP | 25 mg 0.490% w/v q.s |
49 | METHOTREXATE INJECTION USP 500 mg/5 ml | Each ml contains Methotrexate USP Sodium chloride USP Water for injection USP | 100 mg 0.490% w/v q.s |
50 | METHOTREXATE INJECTION USP 1000 mg/10 ml | Each ml contains Methotrexate USP Sodium chloride USP Water for injection USP | 100 mg 0.490% w/v q.s |
51 | MELPHALAN FOR INJECTION 50 mg | Each sterile lyophilized vial contains Melphalan USP | 50 mg |
52 | MITOMYCIN FOR INJECTION USP 2 mg | Each sterile lyophilized vial contains Metomycin USP Mannitol USP | 2mg, 10 mg |
53 | MITOMYCIN FOR INJECTION USP 10 mg | Each sterile lyophilized vial contains Metomycin USP Mannitol USP | 10mg, 20 mg |
54 | MITOMYCIN FOR INJECTION USP 20 mg | Each sterile lyophilized vial contains Metomycin USP Mannitol USP | 20mg, 40 mg |
55 | MITOMYCIN FOR INJECTION USP 40 mg | Each sterile lyophilized vial contains Metomycin USP Mannitol USP | 40mg, 80 mg |
56 | MITOXANTRONE INJECTION USP 20 mg/10 ml | Each ml contains Mitoxantrone hydrochloride USP equivalent to Mitoxantrone free base Sodium chloride USP Water for injection USP | 2mg, 8mg, q.s |
57 | MITOXANTRONE INJECTION USP 30 mg/15 ml | Each ml contains Mitoxantrone hydrochloride USP equivalent to Mitoxantrone free base Sodium chloride USP Water for injection USP | 2mg, 8mg, q.s |
58 | OXALIPLATIN FOR INJECTION 50 mg | Each sterile lyophilized vial contains Oxaliplatin Ph.Eur Lactose USNF | 50mg, 450mg, |
59 | OXALIPLATIN FOR INJECTION 100 mg | Each sterile lyophilized vial contains Oxaliplatin Ph.Eur Lactose USNF | 100mg, 900mg, |
60 | PACLITAXEL INJECTION USP 30 mg/5 Ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
61 | PACLITAXEL INJECTION USP 100 mg/16.7 ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
62 | PACLITAXEL INJECTION USP 150 mg/25 ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
63 | PACLITAXEL INJECTION USP 250 mg/41.7 ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
64 | PACLITAXEL INJECTION USP 260 mg/43.3 ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
65 | PACLITAXEL INJECTION USP 300 mg/50 ml | Each ml contains Paclitaxel USP Polyoxyl 35 Castor oil USNF Dehydrated alcohol USP | 6mg, 527mg, 49.7% v/v |
66 | TOPOTECAN HYDROCHLORIDE FOR INJECTION 4 mg | Each sterile lyophilized vial contains Topotecan hydrochloride equivalent to Topotecan | 4 mg |
67 | VINBLASTINE SULFATE FOR INJECTION USP 10 mg | Each sterile lyophilized vial contains Vinblastine Sulfate USP | 10 mg |
68 | VINCRISTINE SULFATE FOR INJECTION USP 1 mg | Each sterile lyophilized vial contains Vinblastine Sulfate USP | 1mg |
69 | VINCRISTINE SULFATE FOR INJECTION USP 2 mg | Each sterile lyophilized vial contains Vinblastine Sulfate USP | 2 mg |
70 | VINCRISTINE SULFATE FOR INJECTION USP 1 mg | Each ml contains Vincrystine sulfate USP | 1 mg |
71 | VINCRISTINE SULFATE FOR INJECTION USP 2 mg | Each ml contains Vincrystine sulfate USP | 1 mg |
72 | VINORELBINE INJECTION USP 10 mg/1 ml | Each ml contains Vinorelbine tartarate USP equivalent to Vinorelbine | 10 mg |
73 | VINORELBINE INJECTION USP 50 mg/5 ml | Each ml contains Vinorelbine tartarate USP equivalent to Vinorelbine | 10 mg |